Long term IL-17A inhibition by secukinumab leads to reduced spinal inflammation and unchanged fatty lesions in patients with ankylosing spondylitis
ZEITSCHRIFT FUR RHEUMATOLOGIE(2013)
关键词
ankylosing spondylitis,spinal inflammation,secukinumab leads,unchanged fatty lesions
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要